The Valley Desk

NCT04832724 · Interventional trial

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Overall registry status Completed

Phase 2

Conditions Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration, Wet Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov